BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21224495)

  • 1. Intramyocardial protein therapy with vascular endothelial growth factor (VEGF-165) induces functional angiogenesis in rat senescent myocardium.
    Besse S; Boucher F; Linguet G; Riou L; De Leiris J; Riou B; Dimastromatteo J; Comte R; Courty J; Delbe J
    J Physiol Pharmacol; 2010 Dec; 61(6):651-61. PubMed ID: 21224495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotrophin promotes capillary-like sprouting from senescent aortic rings.
    Besse S; Comte R; Fréchault S; Courty J; Joël de L; Delbé J
    Cytokine; 2013 Apr; 62(1):44-7. PubMed ID: 23481101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired angiogenesis in aging myocardial microvascular endothelial cells is associated with reduced importin alpha and decreased nuclear transport of HIF1 alpha: mechanistic implications.
    Ahluwalia A; Narula J; Jones MK; Deng X; Tarnawski AS
    J Physiol Pharmacol; 2010 Apr; 61(2):133-9. PubMed ID: 20436213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice.
    Huusko J; Merentie M; Dijkstra MH; Ryhänen MM; Karvinen H; Rissanen TT; Vanwildemeersch M; Hedman M; Lipponen J; Heinonen SE; Eriksson U; Shibuya M; Ylä-Herttuala S
    Cardiovasc Res; 2010 Apr; 86(1):122-30. PubMed ID: 19955220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramyocardial injection of low-dose basic fibroblast growth factor or vascular endothelial growth factor induces angiogenesis in the infarcted rabbit myocardium.
    Bougioukas I; Didilis V; Ypsilantis P; Giatromanolaki A; Sivridis E; Lialiaris T; Mikroulis D; Simopoulos C; Bougioukas G
    Cardiovasc Pathol; 2007; 16(2):63-8. PubMed ID: 17317537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body hyperthermia induces up-regulation of vascular endothelial growth factor accompanied by neovascularization in cardiac tissue.
    Gong B; Asimakis GK; Chen Z; Albrecht TB; Boor PJ; Pappas TC; Bell B; Motamedi M
    Life Sci; 2006 Oct; 79(19):1781-8. PubMed ID: 16979666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor blockade prevents the beneficial effects of β-blocker therapy on cardiac function, angiogenesis, and remodeling in heart failure.
    Rengo G; Cannavo A; Liccardo D; Zincarelli C; de Lucia C; Pagano G; Komici K; Parisi V; Scala O; Agresta A; Rapacciuolo A; Perrone Filardi P; Ferrara N; Koch WJ; Trimarco B; Femminella GD; Leosco D
    Circ Heart Fail; 2013 Nov; 6(6):1259-67. PubMed ID: 24029661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.
    Hu CH; Wu GF; Wang XQ; Yang YH; Du ZM; He XH; Xiang P
    Chin Med J (Engl); 2006 Sep; 119(18):1499-506. PubMed ID: 16996002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation.
    Bry M; Kivelä R; Holopainen T; Anisimov A; Tammela T; Soronen J; Silvola J; Saraste A; Jeltsch M; Korpisalo P; Carmeliet P; Lemström KB; Shibuya M; Ylä-Herttuala S; Alhonen L; Mervaala E; Andersson LC; Knuuti J; Alitalo K
    Circulation; 2010 Oct; 122(17):1725-33. PubMed ID: 20937974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure.
    Banquet S; Gomez E; Nicol L; Edwards-Lévy F; Henry JP; Cao R; Schapman D; Dautreaux B; Lallemand F; Bauer F; Cao Y; Thuillez C; Mulder P; Richard V; Brakenhielm E
    Circulation; 2011 Aug; 124(9):1059-69. PubMed ID: 21824923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic blockade prevents the decrease in cardiac VEGF expression and capillary supply in experimental renal failure.
    Amann K; Odoni G; Benz K; Campean V; Jacobi J; Hilgers KF; Hartner A; Veelken R; Orth SR
    Am J Physiol Renal Physiol; 2011 Jan; 300(1):F105-12. PubMed ID: 20962116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An adenovirus-mediated gene-transfer model of angiogenesis in rat mesentery.
    Wang WY; Whittles CE; Harper SJ; Bates DO
    Microcirculation; 2004 Jun; 11(4):361-75. PubMed ID: 15280075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of phospho-adenosine monophosphate-activated protein kinase and vascular endothelial growth factor in a model of chronic heart failure.
    Heidrich F; Sossalla S; Schotola H; Vorkamp T; Ortmann P; Popov AF; Coskun KO; Rajab TK; Friedrich M; Sohns C; Hinz J; Bauer M; Quintel M; Schöndube FA; Schmitto JD
    Artif Organs; 2010 Nov; 34(11):969-79. PubMed ID: 21092039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats.
    Chen J; Zhang ZG; Li Y; Wang L; Xu YX; Gautam SC; Lu M; Zhu Z; Chopp M
    Circ Res; 2003 Apr; 92(6):692-9. PubMed ID: 12609969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF.
    Hughes GC; Biswas SS; Yin B; Coleman RE; DeGrado TR; Landolfo CK; Lowe JE; Annex BH; Landolfo KP
    Ann Thorac Surg; 2004 Mar; 77(3):812-8. PubMed ID: 14992878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation.
    Kupatt C; Hinkel R; Pfosser A; El-Aouni C; Wuchrer A; Fritz A; Globisch F; Thormann M; Horstkotte J; Lebherz C; Thein E; Banfi A; Boekstegers P
    J Am Coll Cardiol; 2010 Jul; 56(5):414-22. PubMed ID: 20650363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles.
    Korpanty G; Chen S; Shohet RV; Ding J; Yang B; Frenkel PA; Grayburn PA
    Gene Ther; 2005 Sep; 12(17):1305-12. PubMed ID: 15829992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis.
    Friehs I; Margossian RE; Moran AM; Cao-Danh H; Moses MA; del Nido PJ
    Basic Res Cardiol; 2006 May; 101(3):204-13. PubMed ID: 16369727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental coronary maturation is disturbed by aberrant cardiac vascular endothelial growth factor expression and Notch signalling.
    van den Akker NM; Caolo V; Wisse LJ; Peters PP; Poelmann RE; Carmeliet P; Molin DG; Gittenberger-de Groot AC
    Cardiovasc Res; 2008 May; 78(2):366-75. PubMed ID: 18093989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.